Patent · US Active

Compounds for cancer chemotherapeutic sensitization

US10617706B2 · kind B2 · utility

0Cited by

1References

17Claims

0Family size

Assignees

Regents of the University of Minnesota · US
The USA, as represented by the Secretary, Dept. of Health and Human Services · US

Inventors

Zhengqiang Wang · Eden Prairie, US
Jayakanth Kankanala · Windom, US
Yves G. Pommier · Bethesda, US

Key dates

Filing date	Feb 4, 2019
Grant date	Apr 14, 2020
Priority date	—
Expiry date	Feb 4, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F5/025
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides a compound of formula (I), (II) or (III): wherein R1, R2, R3, R4 and R5 have any of the values described in the specification, as well as compositions comprising a compound of formula (I), (II) or (III). The compounds and compositions are useful as chemotherapeutic sensitizing agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.